Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT01818661
PHASE4
Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech
Sponsor: Mayo Clinic
View on ClinicalTrials.gov
Summary
The study is designed to determine the relationship between structural and functional changes in the brain on imaging and progression of speech and language, neurological and neuropsychological features in patients with neurodegenerative apraxia of speech (AOS).
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2018-07-01
Completion Date
2028-06
Last Updated
2025-11-12
Healthy Volunteers
No
Conditions
Interventions
DRUG
AV-1451
This is used to assess Tau burden in the brain.
Locations (1)
Mayo Clinic
Rochester, Minnesota, United States